Singh, K., Foster, M., Violette, M., Corcoran, A., Hotchkiss, K., Railton, C., … Khasraw, M. (2024). A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8⁺ infiltration in glioma. medRxiv. https://doi.org/10.1101/2024.06.19.24309192

Singh, Kirit, Matthew Foster, Marlene Violette, Anna Corcoran, Kelly Hotchkiss, Chelsea Railton, Emily Blandford, et al. “A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8⁺ infiltration in glioma.” MedRxiv, 2024. https://doi.org/10.1101/2024.06.19.24309192.

Singh K, Foster M, Violette M, Corcoran A, Hotchkiss K, Railton C, et al. A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8⁺ infiltration in glioma. medRxiv. 2024.

Singh, Kirit, et al. “A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8⁺ infiltration in glioma.” MedRxiv, 2024. Epmc, doi:10.1101/2024.06.19.24309192.

Singh K, Foster M, Violette M, Corcoran A, Hotchkiss K, Railton C, Blandford E, Blethen K, McIntosh W, Thomas E, Ashley D, Desjardins A, Friedman H, Johnson M, Friedman A, Keir S, Buckley E, Herndon J, McLendon R, Sampson J, Calabrese E, Lopez G, Grant G, Patel A, Gregory S, Li C-Y, Fecci P, Khasraw M. A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8⁺ infiltration in glioma. medRxiv. 2024.